Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study

<p>Abstract</p> <p>Background</p> <p>One of the main uses of seroprevalence studies it to evaluate vaccination programmes. In 1998, a programme of universal vaccination of preadolescents in schools with the hepatitis A vaccine was begun in Catalonia. The objective of th...

Full description

Bibliographic Details
Main Authors: Costa Josep, Espuñes Jordi, Plans Pere, Bruguera Miquel, Domínguez Àngela, Plasencia Antoni, Salleras Lluis
Format: Article
Language:English
Published: BMC 2007-07-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/7/73
_version_ 1811246725290000384
author Costa Josep
Espuñes Jordi
Plans Pere
Bruguera Miquel
Domínguez Àngela
Plasencia Antoni
Salleras Lluis
author_facet Costa Josep
Espuñes Jordi
Plans Pere
Bruguera Miquel
Domínguez Àngela
Plasencia Antoni
Salleras Lluis
author_sort Costa Josep
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>One of the main uses of seroprevalence studies it to evaluate vaccination programmes. In 1998, a programme of universal vaccination of preadolescents in schools with the hepatitis A vaccine was begun in Catalonia. The objective of this study was to investigate the prevalence and risk factors of hepatitis A virus infection (HAV) in a sample of the adult population of Catalonia in 2002 and to evaluate the changes with respect to a survey carried out in 1996.</p> <p>Methods</p> <p>The prevalence of HAV antibodies was determined by a third generation competitive immunometric assay in a representative sample of 1292 people aged >15 years. The association between the prevalence and different sociodemographic variables was determined by multiple logistic regression analysis.</p> <p>Results</p> <p>The standardized global prevalence of HAV antibodies in 2002 was 68.2%, increased with age (p < 0.0001) and was associated with being born outside Catalonia (OR: 1.75; 95% CI 1.11–2.76) and lower social class (OR: 1.14; 95% CI 1.05–1.25). Compared with the last survey carried out in 1996 the standardized global prevalence was lower (68.2% vs 77.8%; p < 0.0001) as was the prevalence in people under 45 years.</p> <p>Conclusion</p> <p>The prevalence of the hepatitis A virus is decreasing in the adult population of Catalonia, especially in the younger age groups. The programme of vaccination of adolescents begun in 1998 to control the disease can provide indirect protection to the unvaccinated population.</p>
first_indexed 2024-04-12T14:57:33Z
format Article
id doaj.art-ec9b80e6dbd443568a9987e5a914d6de
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-04-12T14:57:33Z
publishDate 2007-07-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-ec9b80e6dbd443568a9987e5a914d6de2022-12-22T03:28:11ZengBMCBMC Infectious Diseases1471-23342007-07-01717310.1186/1471-2334-7-73Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based studyCosta JosepEspuñes JordiPlans PereBruguera MiquelDomínguez ÀngelaPlasencia AntoniSalleras Lluis<p>Abstract</p> <p>Background</p> <p>One of the main uses of seroprevalence studies it to evaluate vaccination programmes. In 1998, a programme of universal vaccination of preadolescents in schools with the hepatitis A vaccine was begun in Catalonia. The objective of this study was to investigate the prevalence and risk factors of hepatitis A virus infection (HAV) in a sample of the adult population of Catalonia in 2002 and to evaluate the changes with respect to a survey carried out in 1996.</p> <p>Methods</p> <p>The prevalence of HAV antibodies was determined by a third generation competitive immunometric assay in a representative sample of 1292 people aged >15 years. The association between the prevalence and different sociodemographic variables was determined by multiple logistic regression analysis.</p> <p>Results</p> <p>The standardized global prevalence of HAV antibodies in 2002 was 68.2%, increased with age (p < 0.0001) and was associated with being born outside Catalonia (OR: 1.75; 95% CI 1.11–2.76) and lower social class (OR: 1.14; 95% CI 1.05–1.25). Compared with the last survey carried out in 1996 the standardized global prevalence was lower (68.2% vs 77.8%; p < 0.0001) as was the prevalence in people under 45 years.</p> <p>Conclusion</p> <p>The prevalence of the hepatitis A virus is decreasing in the adult population of Catalonia, especially in the younger age groups. The programme of vaccination of adolescents begun in 1998 to control the disease can provide indirect protection to the unvaccinated population.</p>http://www.biomedcentral.com/1471-2334/7/73
spellingShingle Costa Josep
Espuñes Jordi
Plans Pere
Bruguera Miquel
Domínguez Àngela
Plasencia Antoni
Salleras Lluis
Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study
BMC Infectious Diseases
title Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study
title_full Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study
title_fullStr Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study
title_full_unstemmed Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study
title_short Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study
title_sort declining hepatitis a seroprevalence in adults in catalonia spain a population based study
url http://www.biomedcentral.com/1471-2334/7/73
work_keys_str_mv AT costajosep declininghepatitisaseroprevalenceinadultsincataloniaspainapopulationbasedstudy
AT espunesjordi declininghepatitisaseroprevalenceinadultsincataloniaspainapopulationbasedstudy
AT planspere declininghepatitisaseroprevalenceinadultsincataloniaspainapopulationbasedstudy
AT brugueramiquel declininghepatitisaseroprevalenceinadultsincataloniaspainapopulationbasedstudy
AT dominguezangela declininghepatitisaseroprevalenceinadultsincataloniaspainapopulationbasedstudy
AT plasenciaantoni declininghepatitisaseroprevalenceinadultsincataloniaspainapopulationbasedstudy
AT salleraslluis declininghepatitisaseroprevalenceinadultsincataloniaspainapopulationbasedstudy